EMPLOYMENT AGREEMENTEmployment Agreement • August 18th, 2020 • Lixte Biotechnology Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 18th, 2020 Company Industry JurisdictionThis Employment Agreement (“Agreement”) is entered into as of August 12, 2020 by and between Lixte Biotechnology Holdings Inc., a Delaware corporation having its principal place of business located at 248 Route 25A, No. 2, East Setauket, NY 11733 (“Company”), and Robert N. Weingarten (“Employee”), an individual residing at 5439 Lockhurst Dr., Woodland Hills, CA 91367.
MASTER SERVICE AGREEMENTMaster Service Agreement • August 18th, 2020 • Lixte Biotechnology Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 18th, 2020 Company Industry JurisdictionThis Master Service Agreement (“Agreement”) is dated as of August 12, 2020 (the “Effective Date”) by and between FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS, “FAST”, a California corporation with a principal place of business in Illinois, US, and Lixte Biotechnology Holdings, Inc., a Delaware corporation (“Company”). FAST and Company may be referred to herein as a “Party” or, collectively, as “Parties”.